Page Not Found
The page you are looking for doesn't exist or another error occurred.
Please use the menu above or the search form below to try another section.
Latest News
16th June 2026
‘Sugar-coated’ tumour matrix may offer way to make triple-negative breast cancer easier to treat
Researchers have discovered a way in which the environment surrounding triple-negative breast cancer cells helps suppress our immune system, making this cancer harder to treat. The findings open the door to a potential new treatment strategy that could make triple-negative breast cancers more vulnerable to the immune system and help more people to benefit from immunotherapy in future.
21st May 2026
Professor Louise Jones elected Fellow of the Academy of Medical Sciences
Professor Louise Jones at Barts Cancer Institute, Queen Mary University of London, has been elected to the Academy of Medical Sciences. She joins 60 exceptional biomedical and health scientists elected to its prestigious Fellowship.
5th May 2026
Study offers clues to blood cancer risk, revealing how gene mutations compete over time
Researchers have developed a new way to understand how genetic changes linked to blood cancer evolve in our cells, offering new insight into predicting blood cancer risk.
8th April 2026
New £1m clinical trial launches to improve quality of life for people with blood cancer
Dr Kevin Rouault-Pierre and team at Barts Cancer Institute, Queen Mary University of London, have been awarded funding to launch a new clinical trial aiming to improve quality of life for people living with a form of blood cancer called myelodysplastic syndromes, which currently has limited treatment options.
25th March 2026
Lab-grown ovarian ‘mini-tumours’ provide new tool for immunotherapy research
Researchers have developed a way to grow miniature ovarian tumours in the lab that mimic the tumour environment found in patients. The new approach offers a useful way to study how cancer cells interact with the immune system and to explore potential treatments. Ultimately, it could help accelerate progress for patients and reduce reliance on research methods involving animals.
11th March 2026
Barts Cancer Institute teams awarded nearly £3m from Cancer Research UK to seek novel cancer therapy targets
Professor Michelle Lockley and Dr Oliver Pearce have both been awarded prestigious Programme Foundation Awards from Cancer Research UK, worth nearly £1.5 million each, to support the work of their research groups at Barts Cancer Institute, Queen Mary University of London.